AIWall Street Journalabout 2 hours ago
Takeda, InSilico Strike $600M AI Drug Deal
1 min read
Takeda and InSilico Medicine signed an AI drug-discovery deal worth up to $600 million. The partnership aims to leverage InSilico's artificial intelligence platform to identify and develop new drug candidates for Takeda's pipeline.
Level
Hype check
Tap to vote and see what everyone thinks.
